TLR 4 agonist（Hephaistos-Pharma）

N/A

Report date: 2022/08/29 17:36:03

Base Information

Drug NameTLR 4 agonist（Hephaistos-Pharma）
Drug Alias NameTLR 4 agonist
ClassificationOther
Mechanisms of ActionToll like receptor 4 agonists
TargetsToll like receptor 4
Therapy Area/IndicationsOsteosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHephaistos-Pharma
China Registration ClassN/A

Develop Information

Active CompaniesHephaistos-Pharma
Inactive CompaniesN/A
Active IndicationsOsteosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A